Status:
RECRUITING
NeuroPathways Intervention for Brain Tumor Patients
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Malignant Brain Tumor
Glioma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumo...
Detailed Description
This study will be a prospective pilot randomized controlled trial to examine the feasibility and acceptability of a novel, population-specific intervention designed to help patients with recently-dia...
Eligibility Criteria
Inclusion
- Age ≥18
- Massachusetts General Hospital Cancer Center patient
- Within 6 weeks of diagnosis with a primary malignant brain tumor
- Able to speak and read in English
Exclusion
- Inability to provide informed consent as assessed by the study team (e.g., due to neurological impairment such as severe cognitive impairment/dementia or moderate-to-severe receptive aphasia)
- Deemed inappropriate to approach by patient's oncologist or study PI
Key Trial Info
Start Date :
November 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 10 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05976490
Start Date
November 7 2023
End Date
April 10 2027
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114